ketoconazole has been researched along with Blood Pressure, Low in 1 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ketoconazole may cause severe anaphylactic shock even when taken orally." | 1.33 | Refractory anaphylactic shock associated with ketoconazole treatment. ( Chen, JH; Lee, CH; Lin, LJ; Liu, PY, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, PY | 1 |
| Lee, CH | 1 |
| Lin, LJ | 1 |
| Chen, JH | 1 |
1 other study available for ketoconazole and Blood Pressure, Low
| Article | Year |
|---|---|
Refractory anaphylactic shock associated with ketoconazole treatment.
Topics: Aged; Anaphylaxis; Antifungal Agents; Candidiasis; Eye Infections, Fungal; Female; Humans; Hypotensi | 2005 |